Skip to main content

Leiomyosarcoma

  • Chapter
  • First Online:
Soft Tissue Tumors
  • 76 Accesses

Abstract

Leiomyosarcoma is a malignant tumor originating from smooth muscle cells. In this section the so-called deep soft tissue leiomyosarcoma is considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Readings

  • Bonvalot (2019) STRASS (EORTC 62092): a phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. J Clin Oncol 37(15_suppl):11001

    Article  Google Scholar 

  • D’Ambrosio (2020) Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer 126(11):2637–2647

    Article  Google Scholar 

  • Demetri (2016) Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized multicenter clinical trial. J Clin Oncol 34(8):786–793

    Article  CAS  Google Scholar 

  • Fletcher (2020) WHO classification of tumours of soft tissue and bone (5th edition)

    Google Scholar 

  • Gronchi (2017) Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol 18(6):812–822

    Article  CAS  Google Scholar 

  • Pantoja (2020) Caval reconstruction with undersized ringed graft after resection of inferior vena cava leiomyosarcoma. Ann Vasc Surg 65:25–32

    Article  Google Scholar 

  • Patel (2019) Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. Cancer 125(15):2610–2620

    Article  CAS  Google Scholar 

  • Shannon-Lowe (2019) The global landscape of EBV-associated tumors. Front Oncol 9:713

    Article  Google Scholar 

  • van der Graaf Winette (2012) Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 379:1879–1886

    Article  CAS  Google Scholar 

  • Vella (2020) Case of primary hepatic leiomyosarcoma successfully treated with laparoscopic right hepatectomy. BMJ Case Rep 13(2):e233567

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone Mocellin .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mocellin, S. (2021). Leiomyosarcoma. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_148

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-58710-9_148

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-58709-3

  • Online ISBN: 978-3-030-58710-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics